Journal article icon

Journal article

Therapeutic vaccines in HBV: lessons from HCV

Abstract:

Currently, millions of people infected with hepatitis B virus (HBV) are committed to decades of treatment with anti-viral therapy to control viral replication. However, new tools for immunotherapy that include both viral vectors and molecular checkpoint inhibitors are now available. This has led to a resurgence of interest in new strategies to develop immunotherapeutic strategies with the aim of inducing HBeAg seroconversion--an end-point that has been associated with a decrease in the rates ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1007/s00430-014-0376-8

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Experimental Medicine Division
More from this funder
Funding agency for:
Barnes, E
Publisher:
Springer Berlin Heidelberg Publisher's website
Journal:
Medical Microbiology and Immunology Journal website
Volume:
204
Issue:
1
Pages:
79-86
Publication date:
2015-02-05
DOI:
EISSN:
1432-1831
ISSN:
0300-8584
URN:
uuid:4d480b01-61dc-43cb-abb8-eeb948a3e4bb
Source identifiers:
503413
Local pid:
pubs:503413

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP